Video

IBS Days: bridging science and clinical practice in irritable bowel syndrome

Giovanni Barbara (University of Bologna), Congress Chair, reflects on the key takeaways from the congress and shares his closing remarks.

Beyond antibiotic-associated diarrhea: probiotics, the gut microbiota, and the challenge of antimicrobial resistance

Francisco Guarner, from Centro Médico Teknon in Barcelona, discusses the role of probiotics in the prevention of antibiotic-associated diarrhea.

Mapping the microbiome: ranking gut species linked to diet and cardiometabolic health

Francesco Asnicar, CIBIO - University of Trento (Italy), discusses new large-scale research on the human microbiome, based on the analysis of more than 35,000 individuals from the UK and the…

From stool reports to real-time decisions: making microbiome testing clinically actionable

Amine Zorgani explains how SwipeBiome moves beyond traditional stool testing toward real-time microbiome prediction based on patient metadata.

How microbial metabolites shape allergy, asthma and obesity-related inflammation

Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.

Dietary fiber and gastric cancer: pooled international data support a dose-dependent protective effect

Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.

IBS Days 2026: Bologna to host the European launch of the new Rome V criteria

The fifth edition of IBS Days, a congress entirely dedicated to Irritable Bowel Syndrome, will take place in Bologna, Italy, from June 15 to 17, 2026.

Postbiotics as a new frontier in healthcare: from gut barrier function to cancer immunotherapy

Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.

Targeting the gut microbiota in IBD: from diet and probiotics to fecal microbiota transplantation

Giovanni Marasco, University of Bologna, discusses the growing evidence that links gut microbiota dysbiosis to the pathophysiology, clinical prognosis, disease progression, and treatment response of patients with IBD.

The food matrix: understanding how foods influence health beyond single nutrients

Ivana Gandolfi, International Diary Federation, describes the emerging concept of the food matrix.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.